Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Shareholders Equity (Quarterly): 224.52M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 224.52M |
| June 30, 2023 | 234.08M |
| March 31, 2023 | 245.49M |
| December 31, 2022 | 207.62M |
| September 30, 2022 | 218.59M |
| June 30, 2022 | 229.00M |
| Date | Value |
|---|---|
| March 31, 2022 | 237.85M |
| December 31, 2021 | 246.43M |
| September 30, 2021 | -50.14M |
| June 30, 2021 | -44.07M |
| December 31, 2020 | -34.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-50.14M
Minimum
Sep 2021
246.43M
Maximum
Dec 2021
155.92M
Average
224.52M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 1.254B |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 234.63M |
| Total Liabilities (Quarterly) | 10.10M |